It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Insomnia symptoms are highly prevalent and associated with several adverse medical conditions, but only few determinants, including non-modifiable ones, have been highlighted. We investigated associations between body silhouette trajectories over the lifespan and insomnia symptoms in adulthood. From a community-based study, 7 496 men and women aged 50–75 years recalled their body silhouette at age 8, 15, 25, 35 and 45, and rated the frequency of insomnia symptoms on a standardized sleep questionnaire. An Epworth Sleepiness Scale ≥11 defined excessive daytime sleepiness (EDS). Using a group-based trajectory modeling, we identified five body silhouette trajectories: a ‘lean-stable’ (32.7%), a ‘heavy-stable’ (8.1%), a ‘moderate-stable’ (32.5%), a ‘lean-increase’ (11%) and a ‘lean-marked increase’ (15.7%) trajectory. In multivariate logistic regression, compared to the ‘lean-stable’ trajectory, the ‘lean-marked increase’ and ‘heavy-stable’ trajectories were associated with a significant increased odd of having ≥1 insomnia symptoms as compared to none and of having a proxy for insomnia disorder (≥1 insomnia symptom and EDS). The association with the ‘lean-marked increase' trajectory’ was independent from body mass index measured at study recruitment. In conclusion, increasing body silhouette over the lifespan is associated with insomnia symptoms in adulthood, emphasizing the importance of weight gain prevention during the entire lifespan.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France (GRID:grid.10992.33) (ISNI:0000 0001 2188 0914); INSERM, UMR-S970, Paris Cardiovascular Research Center, Department of Epidemiology, Paris, France (GRID:grid.462416.3) (ISNI:0000 0004 0495 1460); AP-HP, Georges Pompidou European Hospital, Department of Head and Neck surgery, Paris, France (GRID:grid.414093.b)
2 Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France (GRID:grid.10992.33) (ISNI:0000 0001 2188 0914); INSERM, UMR-S970, Paris Cardiovascular Research Center, Department of Epidemiology, Paris, France (GRID:grid.462416.3) (ISNI:0000 0004 0495 1460)
3 Preventive and Clinical Investigation Center, Paris, France (GRID:grid.462416.3)
4 Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France (GRID:grid.10992.33) (ISNI:0000 0001 2188 0914); INSERM, UMR-S970, Paris Cardiovascular Research Center, Department of Epidemiology, Paris, France (GRID:grid.462416.3) (ISNI:0000 0004 0495 1460); AP-HP, Georges Pompidou European Hospital, Department of Pharmacology, Paris, France (GRID:grid.414093.b)
5 Lausanne University Hospital, Lausanne University, Center for Investigation and Research in Sleep, Lausanne, Switzerland (GRID:grid.462416.3)
6 Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France (GRID:grid.10992.33) (ISNI:0000 0001 2188 0914); INSERM, UMR-S970, Paris Cardiovascular Research Center, Department of Epidemiology, Paris, France (GRID:grid.462416.3) (ISNI:0000 0004 0495 1460); University of Tasmania, Menzies Institute for Medical Research, Hobart, Australia (GRID:grid.1009.8) (ISNI:0000 0004 1936 826X)
7 Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France (GRID:grid.10992.33) (ISNI:0000 0001 2188 0914); INSERM, UMR-S970, Paris Cardiovascular Research Center, Department of Epidemiology, Paris, France (GRID:grid.462416.3) (ISNI:0000 0004 0495 1460); Maastricht University, CARIM School for Cardiovascular Diseases, Maastricht, The Netherlands (GRID:grid.5012.6) (ISNI:0000 0001 0481 6099); Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382)
8 Preventive and Clinical Investigation Center, Paris, France (GRID:grid.412966.e)
9 Lausanne University Hospital, Lausanne University, Center for Investigation and Research in Sleep, Lausanne, Switzerland (GRID:grid.412966.e); Lausanne University Hospital, Department of medicine, Service of internal medicine, Lausanne, Switzerland (GRID:grid.8515.9) (ISNI:0000 0001 0423 4662)
10 Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France (GRID:grid.10992.33) (ISNI:0000 0001 2188 0914); INSERM, UMR-S970, Paris Cardiovascular Research Center, Department of Epidemiology, Paris, France (GRID:grid.462416.3) (ISNI:0000 0004 0495 1460); AP-HP, Georges Pompidou European Hospital, Cardiology Department, Paris, France (GRID:grid.414093.b)